1
0
0
(1 - 13 von 13
)
Nature CommunicationsRePEc
ideas.repec.org
... Volta & Christina Lindner & Omar El Bounkari & Kathleen Hille & Yuan Tian & Xènia Puig-Bosch & Markus Ballmann & Simon Hornung & Martin Ortner & Sophia ...
Blocking Inflammasome Activation Caused by β-Amyloid ...American Chemical Society
pubs.acs.org
von M Aftabizadeh · · Zitiert von: 15 — ... Omar El Bounkari, Kathleen Hille, Yuan Tian, Xènia Puig-Bosch, Markus Ballmann, Simon Hornung, Martin Ortner, Sophia Prem, Laura Meier, ...
GABAA Receptors withoutMDPI
mdpi-res.com
von X Puig-Bosch · — Xènia Puig-Bosch 1,2,* , Markus Ballmann 1, Stefan Bieletzki 3, Bernd Antkowiak 3, Uwe Rudolph 4,. Hanns Ulrich Zeilhofer 5,6.
Evaluating the Role of Microglial Cells in Clearance of Aβ from ...
pubs.acs.org
von AL Manchikalapudi · · Zitiert von: 12 — ... Omar El Bounkari, Kathleen Hille, Yuan Tian, Xènia Puig-Bosch, Markus Ballmann, Simon Hornung, Martin Ortner, Sophia Prem, Laura Meier, ... › doi › abs
Designed peptides as nanomolar cross-amyloid inhibitors ...
europepmc.org
von K Taş · · Zitiert von: 1 — ... Omar El Bounkari,2 Kathleen Hille,1 Yuan Tian,2 Xènia Puig-Bosch,3Markus Ballmann,3 Simon Hornung,1 Martin Ortner,1,11 Sophia Prem,1, › articles › bin
Alzheimer's disease and type 2 diabetes: Synthetic ...Science Daily
www.sciencedaily.com
— ... Omar El Bounkari, Kathleen Hille, Yuan Tian, Xènia Puig-Bosch, Markus Ballmann, Simon Hornung, Martin Ortner, Sophia Prem, Laura Meier, ...
Designed peptides as nanomolar cross-amyloid inhibitors acting via...
www.nature.com
von K Taş · — Xènia Puig-Bosch, Markus Ballmann & Gerhard Rammes. Center for Protein Assemblies, Department of Chemistry, Technical University of Munich, ... › articles
Designed peptides as nanomolar cross-amyloid inhibitors acting via...
www.nature.com
von K Taş · · Zitiert von: 1 — Xènia Puig-Bosch, Markus Ballmann & Gerhard Rammes. Center for Protein Assemblies, Department of Chemistry, Technical University of Munich, ... › articles
pubmed.ncbi.nlm.nih.gov › ...Neurosteroids Mediate Neuroprotection in an In Vitro PubMed
pubmed.ncbi.nlm.nih.gov
von X Puig-Bosch · — Xènia Puig-Bosch , Markus Ballmann , Stefan Bieletzki , Bernd Antkowiak , Uwe Rudolph , Hanns Ulrich Zeilhofer , Gerhard Rammes ...
Designed peptides as nanomolar cross-amyloid inhibitors ...Maastricht University
cris.maastrichtuniversity.nl
von K Taş · · Zitiert von: 13 — ... Omar El Bounkari, Kathleen Hille, Yuan Tian, Xènia Puig-Bosch, Markus Ballmann, Simon Hornung, Martin Ortner, Sophia Prem, Laura Meier, ...
MDPI | Article Reprints OrderMDPI
www.mdpi.com
Authors: by Xènia Puig-Bosch, Markus Ballmann, Stefan Bieletzki, Bernd Antkowiak, Uwe Rudolph, Hanns Ulrich Zeilhofer and Gerhard Rammes
Designed peptides as nanomolar cross-amyloid inhibitors acting via...
pubmed.ncbi.nlm.nih.gov
von K Taş · · Zitiert von: 1 — ... Christina Lindner , Omar El Bounkari , Kathleen Hille , Yuan Tian , Xènia Puig-Bosch , Markus Ballmann , Simon Hornung , Martin Ortner ... › ...
Neurosteroids Mediate Neuroprotection in an In Vitro ...MDPI
www.mdpi.com
... of Hypoxic/Hypoglycaemic Excitotoxicity via δ-GABAA Receptors without Affecting Synaptic Plasticity. by. Xènia Puig-Bosch. 1,2,* ,. Markus Ballmann. 1,.
Alle Infos zum Namen "Markus Ballmann"
sortiert nach Relevanz / Datum